Jennison Associates LLC sells 683,468 Revance Therapeutics, Inc. shares (NASDAQ:RVNC)
The most recent 13F filing that Jennison Associates LLC had with the Securities and Exchange Commission revealed that during the third quarter of 2018, the …
RVNC stock news